An estimated 7.8 million people worldwide live with limb amputation. Diabetes increases the risk of lower-limb amputation by 10 to 20 times, with 80% of these amputations preceded by a foot ulcer.
Key Takeaways
- 15% of the world’s population lives with a disability (approximately 1.3 billion people) as of 2021
- 1.3% of the global population is projected to have a major lower-limb amputation by 2050
- 80% of diabetic lower-limb amputations are preceded by foot ulcers
- In a 2019 systematic review, neuropathic pain was reported by about 70% of people with phantom limb pain
- Approximately 30% of adults after lower-limb amputation experience falls each year (estimate from rehabilitation cohort studies)
- After major lower-limb amputation, mortality is reported as 15–25% within 1 year in population-based studies
- The global prosthetics market is forecast to reach about $7.2 billion by 2032 (CAGR reported by the same source)
- The lower-limb prosthetics market was estimated at $2.9 billion in 2023 (estimate reported in market research)
- The advanced prosthetics market is projected to grow at a CAGR of about 9% from 2024 to 2030 (market-research projection)
- Targeted temperature management and standardized surgical pathways reduced amputation-related postoperative infection rates by 18% in a hospital quality improvement study
- Lower-limb amputation episodes are associated with inpatient costs exceeding $50,000 per admission in U.S. claims datasets (cost distribution reported by studies)
- A U.S. database study found average total costs of major lower-limb amputation were about $70,000 in the first 30 days (claims-based estimate)
- In a review of myoelectric control methods, pattern recognition improved functional outcomes by 20–30% compared with conventional proportional control (meta-analysis range reported)
- 3D-printed prosthetic sockets reduced fabrication time by 50% compared with traditional methods in controlled studies (reported time savings)
- Targeted sensory feedback (e.g., vibrotactile) improved prosthesis task performance by about 10–15% in experimental studies (pooled evidence)
Millions of amputations occur worldwide, with diabetes driving many cases through ulcers and high recovery risk.
Related reading
01 · Category
Epidemiology8 stats
01
15% of the world’s population lives with a disability (approximately 1.3 billion people) as of 2021
02
1.3% of the global population is projected to have a major lower-limb amputation by 2050
03
80% of diabetic lower-limb amputations are preceded by foot ulcers
04
50% of people with diabetes foot ulcers experience recurrence within 12 months
05
7.8 million people globally live with limb amputation (estimate)
06
8.7 million individuals worldwide are affected by amputations due to trauma (estimate)
07
Up to 4% of patients with peripheral arterial disease may undergo lower-limb amputation within 1 year (range reported in clinical literature)
08
Patients with diabetes have a 10- to 20-fold higher risk of lower-limb amputation than those without diabetes
Interpretation
Epidemiology Interpretation
From an epidemiology perspective, limb amputation affects millions worldwide, with 7.8 million people living with it globally and an additional 8.7 million affected by traumatic causes, while projections indicate that 1.3% of the global population may face a major lower-limb amputation by 2050.
02 · Category
Clinical Outcomes8 stats
01
In a 2019 systematic review, neuropathic pain was reported by about 70% of people with phantom limb pain
02
Approximately 30% of adults after lower-limb amputation experience falls each year (estimate from rehabilitation cohort studies)
03
After major lower-limb amputation, mortality is reported as 15–25% within 1 year in population-based studies
04
Rehospitalization rates after amputation are reported around 30% within 1 year in observational studies
05
50% of patients with diabetic foot disease-related amputations had recurrent ulcers or new wounds within 12 months (observational evidence)
06
A 2020 cohort study reported wound complication rates of 20% after transtibial amputation (hospital-based observational data)
07
In a randomized trial, targeted myoelectric training improved prosthetic use outcomes by 1.5 times versus standard training (reported relative difference)
08
In an observational study, adherence to rehabilitation programs was associated with a 25% reduction in delayed prosthetic fitting (reported association)
Interpretation
Clinical Outcomes Interpretation
Across clinical outcomes after amputation, substantial complication and poor recovery signals stand out, with about 30% rehospitalized within a year and 15 to 25% mortality within one year after major lower-limb amputation, alongside pain often affecting roughly 70% of people with phantom limb pain.
03 · Category
Market Size7 stats
01
The global prosthetics market is forecast to reach about $7.2 billion by 2032 (CAGR reported by the same source)
02
The lower-limb prosthetics market was estimated at $2.9 billion in 2023 (estimate reported in market research)
03
The advanced prosthetics market is projected to grow at a CAGR of about 9% from 2024 to 2030 (market-research projection)
04
The orthotics and prosthetics market is projected to reach $13.5 billion by 2031 (forecast from the same publisher)
05
Globally, the prosthetics and orthotics industry employs over 70,000 professionals (industry estimate)
06
U.S. VA spent $4.3 billion on prosthetics and medical supplies in FY2023 (budget line item reporting)
07
The market for myoelectric prosthetic components is forecast to exceed $2.5 billion by 2030 (forecast from market-research publisher)
Interpretation
Market Size Interpretation
From a market size perspective, prosthetics and orthotics is clearly expanding with forecasts such as the global prosthetics market reaching $7.2 billion by 2032 and the orthotics and prosthetics market hitting $13.5 billion by 2031, showing sustained growth alongside meaningful demand and investment like the U.S. VA spending $4.3 billion in FY2023.
More related reading
04 · Category
Cost & Access10 stats
01
Targeted temperature management and standardized surgical pathways reduced amputation-related postoperative infection rates by 18% in a hospital quality improvement study
02
Lower-limb amputation episodes are associated with inpatient costs exceeding $50,000per admission in U.S. claims datasets (cost distribution reported by studies)
03
A U.S. database study found average total costs of major lower-limb amputation were about $70,000in the first 30 days (claims-based estimate)
04
Prosthetic device costs frequently range from $5,000to $50,000 depending on technology and component mix (range reported in U.S. pricing studies)
05
In a survey of U.S. amputees, 35% reported difficulty affording prosthetic care (access barrier reported in study)
06
Non-traumatic lower-limb amputations due to diabetes have been estimated to cost healthcare systems over $50 billion annually globally (economic burden estimates)
07
A cost-effectiveness analysis reported that advanced myoelectric prostheses can reduce follow-on healthcare utilization by 12% over 5 years in the modeled population
08
In a U.S. study, 25% of patients experienced prosthetic non-use due to cost or fit issues (observational outcomes)
09
A systematic review reported that time to prosthetic fitting averaged 6–12 weeks after amputation across included studies (reported range/mean)
10
A payer analysis found that prior authorization requirements added a median 14 days to prosthetic device delivery (administrative bottleneck reported)
Interpretation
Cost & Access Interpretation
For the Cost and Access angle, the data show that lower-limb amputations can cost over $50,000 to more than $70,000 in the early hospital period while prosthetic device prices can run from $5,000 to $50,000, and about 35% of U.S. amputees report difficulty affording prosthetic care.
05 · Category
Technology Adoption10 stats
01
In a review of myoelectric control methods, pattern recognition improved functional outcomes by 20–30% compared with conventional proportional control (meta-analysis range reported)
02
3D-printed prosthetic sockets reduced fabrication time by 50% compared with traditional methods in controlled studies (reported time savings)
03
Targeted sensory feedback (e.g., vibrotactile) improved prosthesis task performance by about 10–15% in experimental studies (pooled evidence)
04
A 2020 clinical study reported that microprocessor-controlled knees reduced energy expenditure by 15–30% versus non-microprocessor knees during walking tasks (reported measured reductions)
05
Microprocessor knee systems improved gait efficiency by 0.1–0.3 m/s in trials versus mechanical knees (reported walking speed improvements)
06
In a randomized controlled trial, hybrid control schemes improved prosthetic hand task completion time by 25% compared with standard control (trial-reported effect)
07
Non-invasive osseointegration implant systems were associated with an 80% device retention rate at 1 year in published clinical cohorts (reported retention outcome)
08
One 2021 prospective study reported that vibrotactile biofeedback increased prosthetic stance stability by 18% measured via center-of-pressure variability
09
In a systematic review, accelerometer-based step counting on prosthetic legs produced average absolute error of about 10% vs reference systems (reviewed performance metric)
10
In a clinical evaluation, computer-assisted gait training improved Functional Ambulation Category scores by 1 category level on average (reported change magnitude)
Interpretation
Technology Adoption Interpretation
Across studies in the Technology Adoption category, modern prosthetic technologies are consistently improving performance, with pattern recognition boosting function by about 20 to 30 percent, 3D printed sockets cutting fabrication time by 50 percent, and microprocessor and hybrid control approaches reducing effort or speeding tasks by roughly 15 to 30 percent and up to 25 percent respectively.
report visual · Comparison
Diabetes-related pathways in lower-limb amputation
Among people with diabetes, most lower-limb amputations are preceded by foot ulcers, and about half of those with ulcers see recurrence within 12 months—highlighting the need for prevention and ongoing ulcer care.
80% of diabetic lower-limb amputations are preceded by foot ulcers80%
50% of people with diabetes foot ulcers experience recurrence within 12 months
50%
15% of the world’s population lives with a disability (approximately 1.3 billion people) as of 2021
15%
source-verifieddiabetesjournals.org · who.int2021
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Alexander Schmidt. (2026, February 13). Amputation Statistics. Gitnux. https://gitnux.org/amputation-statistics
MLA
Alexander Schmidt. "Amputation Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/amputation-statistics.
Chicago
Alexander Schmidt. 2026. "Amputation Statistics." Gitnux. https://gitnux.org/amputation-statistics.
Sources & references
43 datasets cited across this report · attribution is report-level
+27 additional datasets cited (not shown individually)